Two-year serial whole-brain N-acetyl-L-aspartate in patients with relapsing-remitting multiple sclerosis (Q35938583)

11 August 2017

Two-year serial whole-brain N-acetyl-L-aspartate in patients with relapsing-remitting multiple sclerosis (English)

1 reference

11 August 2017

0 references

D J Rigotti

1

1 reference

11 August 2017

M Inglese

2

1 reference

11 August 2017

I I Kirov

3

1 reference

11 August 2017

E Gorynski

4

1 reference

11 August 2017

N N Perry

5

1 reference

11 August 2017

J S Babb

6

1 reference

11 August 2017

J Herbert

7

1 reference

11 August 2017

R I Grossman

8

1 reference

11 August 2017

O Gonen

9

1 reference

11 August 2017

language of work or name

English

0 references

publication date

18 April 2012

1 reference

11 August 2017

1 reference

11 August 2017

78

1 reference

11 August 2017

18

1 reference

11 August 2017

1383-1389

1 reference

Longitudinal whole-brain N-acetylaspartate concentration in healthy adults

11 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3345790

Neurospectroscopy: the past, present and future

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3345790

Axonal and neuronal pathology in multiple sclerosis: what have we learnt from animal models

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3345790

Imaging outcomes for neuroprotection and repair in multiple sclerosis trials

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3345790

Mechanisms of action of disease-modifying agents and brain volume changes in multiple sclerosis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3345790

Effect of laquinimod on MRI-monitored disease activity in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3345790

Fully automatic segmentation of the brain from T1-weighted MRI using Bridge Burner algorithm

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3345790

Whole-brain N-acetylaspartate as a surrogate marker of neuronal damage in diffuse neurologic disorders.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3345790

N-Acetylaspartate in the CNS: from neurodiagnostics to neurobiology

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3345790

N-acetylaspartate as a marker of neuronal injury in neurodegenerative disease

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3345790

N-acetylaspartate in the vertebrate brain: metabolism and function

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3345790

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3345790

Defining the clinical course of multiple sclerosis: Results of an international survey

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3345790

A fast, reliable, automatic shimming procedure using 1H chemical-shift-imaging spectroscopy

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3345790

Natural history of multiple sclerosis: a unifying concept

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3345790

Neuronal cell injury precedes brain atrophy in multiple sclerosis

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3345790

Diffuse axonal and tissue injury in patients with multiple sclerosis with low cerebral lesion load and no disability

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3345790

Total brain N-acetylaspartate concentration in normal, age-grouped females: quantitation with non-echo proton NMR spectroscopy

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3345790

Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3345790

Long-term clinical relevance of criteria for designating multiple sclerosis as benign after 10 years of disease

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3345790

Detecting treatment effects on brain atrophy in relapsing remitting multiple sclerosis: sample size estimates

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3345790

Serial whole-brain N-acetylaspartate concentration in healthy young adults

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3345790

Reproducibility of the whole-brain N-acetylaspartate level across institutions, MR scanners, and field strengths.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3345790

MRI T2 lesion burden in multiple sclerosis: a plateauing relationship with clinical disability

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3345790

Axonal metabolic recovery and potential neuroprotective effect of glatiramer acetate in relapsing-remitting multiple sclerosis

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3345790

Metabolite changes in early relapsing-remitting multiple sclerosis. A two year follow-up study

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3345790

Axonal metabolic recovery in multiple sclerosis patients treated with interferon beta-1b.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3345790

Serial proton magnetic resonance spectroscopic imaging, contrast-enhanced magnetic resonance imaging, and quantitative lesion volumetry in multiple sclerosis

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3345790

Reversible decreases in N-acetylaspartate after acute brain injury

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3345790

Natural history of multiple sclerosis

24 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22517095

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Longitudinal magnetic resonance spectroscopic imaging of primary progressive multiple sclerosis patients treated with glatiramer acetate: multicenter study

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22517095

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Analysis of macromolecule resonances in 1H NMR spectra of human brain

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22517095

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1212/WNL.0B013E318253D609

1 reference

11 August 2017

1 reference

11 August 2017

PubMed publication ID

22517095

1 reference